Research in the McLaughlin group is focused on two key areas:

• The invention and utilisation of novel sustainable catalytic methodologies for the synthesis of high value molecules.
  
• The discovery and development of small molecule binders to interact with new biological targets. Work is ongoing in a range of diseases including cancer, neurodegeneration and antimicrobial resistance.